Serna Bio

Revona Bio

The company develops an RNA-targeted drug discovery platform to identify small-molecule compounds for pharmaceutical partners and biotechnology firms.

Novarna

This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.

Kerna

This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.

CircNova

This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.

Undecimal Bio

This company develops targeted siRNA delivery molecules for pharmaceutical partners to treat renovascular diseases using an AI-enabled screening platform.

Inceptive Nucleics

This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

Ternary Tx

Ternary Therapeutics develops an artificial intelligence platform to design molecular glue drugs for pharmaceutical companies targeting previously undruggable proteins linked to inflammatory diseases.